To know more about this research:

Digest

Scientific Article

One of the hallmarks of multiple myeloma (MM), a cancer of the bone marrow and one of the most frequent haematological cancers worldwide, is the disruption of the patients’ immune system, which allows the cancer to progress. Now, a study performed by Cristina João, who leads the Myeloma and Lymphoma Research Group at the Champalimaud Centre for the Unknown, and her colleagues, shows how so-called extracellular vesicles (EV’s) released by multiple myeloma cells can drive the disruption of the immune system.

We are seeking a highly motivated technician to support and assist in the operation and services of the Fish Platform of the Champalimaud Foundation. The selected candidate will join a dynamic and detail-oriented team with a strong team spirit.

It is with great enthusiasm that we invite you to register for the second hybrid edition of CRSy, to be held at the Champalimaud Centre for the Unknown (CCU), in a stunning setting on the waterfront in Lisbon, Portugal, from October 19–21.

The overall goal of this event is to highlight examples from international funding entities that are either already piloting or considering implementing different models to allocate research funds, with a particular emphasis on the partial randomisation process, and highlight the perspective of researchers on this topic.

The session will end with a roundtable discussion featuring the views from researchers hosted by Portuguese institutions on whether partial randomisation is an appropriate alternative to the current peer review process.  

To know more about this research:

Digest

Scientific Article

Funded by the MCSA & Citizens action - RAISE is built around a concept of co-creation that will blend Researchers at Schools (RAS) activities with European Researchers’ Nights (ERN) public events over the next two years.